1.
Konstantin Byrgazov, Chantal Blanche Lucini, Peter Valent, Oliver Hantschel, Thomas Lion. BCR-ABL1 compound mutants display differential and dose-dependent responses to ponatinib. Haematologica 2018;103(1):e10-e12; https://doi.org/10.3324/haematol.2017.176347.